| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/21/2008 | CN101181356A Chinese medicine preparation for curing systema digestorium ulcer and preparation method thereof |
| 05/21/2008 | CN101181354A Fructus schizandrae chemical composition group extract and preparation technique |
| 05/21/2008 | CN101181342A Pharmaceutical combination with resisting liver cancer activity |
| 05/21/2008 | CN101181341A Mass control method of ginseng and astragalus hepar kang tablet |
| 05/21/2008 | CN101181340A Astragalus essence effervescent tablets and preparation method thereof |
| 05/21/2008 | CN101181335A Stringy stonecrop dropping pills preparations as well as preparation method |
| 05/21/2008 | CN101181334A Method for preparing purifying article extracted from stabilization type stringy stonecrop |
| 05/21/2008 | CN101181323A Panax as well as preparation method and application of extract thereof |
| 05/21/2008 | CN101181315A New purpose of Yulangsan polysaccharide |
| 05/21/2008 | CN101181293A Oral health lozenge for preventing tooth decay |
| 05/21/2008 | CN101181281A Usage of eleutheroside with anti-inflammatory action or aglycone thereof |
| 05/21/2008 | CN101181255A Medication new purpose of protocatechualdehyde |
| 05/21/2008 | CN101181254A Slimming appetising capsule containing natural capsicine for promoting blood circulation and reducing blood fat |
| 05/21/2008 | CN101181248A Application of white fleece-flower root total acetophenone or acetophenone compounds in the preparation of medicament for curing hepar disease |
| 05/21/2008 | CN101181224A Solid dispersion of entecavir, pharmaceutical composition and preparation method as well as uses thereof |
| 05/21/2008 | CN101181031A Prescription of eight-flavour health preserving gruel and preparing method |
| 05/21/2008 | CN100389194C Insulin secretory cell extract and its application in inducing stem cell differentiation |
| 05/21/2008 | CN100389120C Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease |
| 05/21/2008 | CN100388953C Composite mucosa immunoadjuvant for oral vaccine |
| 05/21/2008 | CN100388951C Dietetic food composition and dietetic method using such composition |
| 05/21/2008 | CN100388945C Fatty liver treating notoginseng preparation and its preparation process |
| 05/21/2008 | CN100388944C Traditional Chinese powder medicine for treating toothache |
| 05/21/2008 | CN100388928C Hepatitis virus resistant Chinese medicinal formulation and method for preparing same |
| 05/21/2008 | CN100388925C Medication composition of replenishing qi to invigorate the spleen, preparation method and usage |
| 05/21/2008 | CN100388924C Method for extracting ferula feruloides medicinal composition |
| 05/21/2008 | CN100388922C Chinese medicinal preparation for treating sorethroat, aphtha and its preparation method |
| 05/21/2008 | CN100388917C Hepatitis B abdominal distension external plaster and its making method |
| 05/21/2008 | CN100388916C Rate controlling membranes for controlled drug delivery device |
| 05/20/2008 | US7375189 administering adiponectin, which inhibits the actions of TGFB and PDGF on hepatic stellate cells and thereby exerts effects of suppressing hepatic fibrosis and promoting the proliferation of normal hepatocytes; treating liver cirrhosis or chronic hepatitis |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375115 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 05/20/2008 | US7375110 Nicotinic cholinergic receptors modulators; pain, neurodegenerative diseases; neurotransmission dysfuctions; central and autonomic nervous systems disorders; 1'-(3-pyridyl)-spiro[1-azabicyclo[2.2.1]heptane-2,3'-pyrrolidine] |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis |
| 05/20/2008 | US7375089 Rehydration composition |
| 05/20/2008 | US7374915 Using 1,4-dihysdroxy-2-naphthoic acid as additive in foods and beverages improving intestinal flora and alleviating abdominal ailments caused by lactose intolerance; for prevention or treatment of metabolic bone disorders |
| 05/20/2008 | US7374912 Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2344308C Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 05/20/2008 | CA2231971C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 05/15/2008 | WO2008057282A1 Calcium receptor modulating agents |
| 05/15/2008 | WO2008057136A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/15/2008 | WO2008056687A1 Novel spiropiperidine derivative |
| 05/15/2008 | WO2008056453A1 Noncarious material and anticarious agent containing rare sugar |
| 05/15/2008 | WO2008056156A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | WO2008055945A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| 05/15/2008 | WO2008012227A3 Pyrazoles as glucokinase activators |
| 05/15/2008 | US20080114079 TRPM2-specfic inhibitors |
| 05/15/2008 | US20080114062 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors |
| 05/15/2008 | US20080114038 Drugs Derived from Diclofenac Containing No-Donor Heterocycles, Composition and Method of Inflammation Treatment |
| 05/15/2008 | US20080114020 Difluoro-Substituted Imidazopyridines |
| 05/15/2008 | US20080114018 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/15/2008 | US20080114014 Treating urinary and fecal incontinence in a patient being treated for a cognitive disorder consisting of one of a group of acute dementia and cognitive impairment by administration of a therapeutic amount of a quaternary ammonium anti-cholinergic muscarinic receptor antagonist |
| 05/15/2008 | US20080114006 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies |
| 05/15/2008 | US20080113963 Prepared by submitting benzimidazole compound to a cyclization reaction; gastric secretion inhibiting and gastric and intestinal protective action properties; for gastrointestinal disorders; for example, 2,3-Dimethyl-8-phenyl-3,6,7,8-tetrahydro-chromeno[7,8-a]imidazole-5-carboxylic acid dimethylamide |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113938 Accelerator for mineral absorption and use thereof |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113905 Biologically active peptide with extended half-life and a slower clearance compared to unPEGylated peptide; PEGylated GLP-1 compounds treat diabetes, obesity, irritable bowel syndrome |
| 05/15/2008 | US20080113903 Prevent mammals tissue injuries |
| 05/15/2008 | US20080112956 Using membrane proteins concentration as cancer indicator |
| 05/15/2008 | US20080112942 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 05/15/2008 | DE102006053071A1 Protein-enthaltender Stoff mit erhöhter Temperaturstabilität Protein-containing material with high thermal stability |
| 05/15/2008 | DE102006052755A1 New peptide derivatives and peptidomimetics are transglutaminase inhibitors useful for the treatment or prophylaxis of e.g. celiac disease, fibrosis, thrombosis, neurodegenerative disorders, Huntington's chorea and Parkinson disease |
| 05/15/2008 | CA2672956A1 Calcium receptor modulating agents |
| 05/15/2008 | CA2669038A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | CA2669019A1 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921065A1 Phenylpyridone derivative |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1920770A1 Therapeutic agent for inflammatory bowel disease and tnf- alpha production inhibitor |
| 05/14/2008 | EP1919911A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists |
| 05/14/2008 | EP1919901A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 05/14/2008 | EP1919897A1 Method of preparing esomeprazole and salts thereof |
| 05/14/2008 | EP1919865A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 05/14/2008 | EP1919493A2 Use of specific trifluoromethyl ketones for preventing and treating pancreatitis |
| 05/14/2008 | EP1806983B1 Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal |
| 05/14/2008 | EP1761273B1 Treatment of non alcoholic steatotic hepatitis (nash) |
| 05/14/2008 | EP1553943B1 Use of tenatoprazole for the treatment of gastroesophageal reflux |
| 05/14/2008 | EP1513525B1 Use of mglur5 antagonists for the treatment of gerd |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | EP1017418B1 Vaccine composition for preventing or treating c hepatitis |
| 05/14/2008 | CN201058126Y Locating and unlocking capsule for smectite segmented intestine |
| 05/14/2008 | CN101180291A Benzimidazole-carboxamide compounds as 5-ht4, receptor agonists |
| 05/14/2008 | CN101180276A 2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 05/14/2008 | CN101180096A Method and composition for treating mucosal disorders |
| 05/14/2008 | CN101180053A Treatment of liver diseases in which iron plays a role in pathogenesis |
| 05/14/2008 | CN101180032A Dental enamel recalcification accelerator and containing the same, oral composition and food or beverage |
| 05/14/2008 | CN101177424A High-purity silybin meglumine, preparation method as well as application in preparing medicine treating hepatitis and liver hurt thereof |
| 05/14/2008 | CN101176780A Medicament for curing hepatic fibrosis and early cirrhosis |
| 05/14/2008 | CN101176777A Chinese medicine composition and extract for preventing and treating stomach and intestine dysfunction as well as application thereof |
| 05/14/2008 | CN101176775A Medicament for curing hepatitis B |
| 05/14/2008 | CN101176765A Chinese medicine detoxication preparations and preparation method thereof |
| 05/14/2008 | CN101176764A Preparation method of deer penis wine |
| 05/14/2008 | CN101176761A Atmosphere regulating cream special for children |
| 05/14/2008 | CN101176759A Process technique for deer fetus wine |